Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013

  Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On
                              February 28, 2013

PR Newswire

NASHVILLE, Tenn., Feb. 14, 2013

NASHVILLE, Tenn., Feb. 14, 2013 /PRNewswire/ --Cumberland Pharmaceuticals
Inc. (NASDAQ: CPIX) announced today that it will release 2012 year-end
financial results after the market closes on Thursday, February 28, 2013. A
conference call and live Internet webcast will be held on Thursday, February
28, 2013, at 4:30 p.m. Eastern Time to discuss the results.

To participate in the call, please dial 877-303-1298 (for U.S. callers) or
253-237-1032 (for international callers). A rebroadcast of the teleconference
will be available for one week and can be accessed by dialing 855-859-2056
(for U.S. callers) or 404-537-3406 (for international callers). The
Conference ID for the rebroadcast is 97366269. The live webcast and
rebroadcast can be accessed via Cumberland's website at

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused
on the acquisition, development and commercialization of branded prescription
products. The Company's primary target markets include hospital acute care and
gastroenterology. Cumberland's marketed products include Acetadote^®
(acetylcysteine) Injection for the treatment of acetaminophen poisoning,
Caldolor^® (ibuprofen) Injection, the first injectable treatment for pain and
fever approved in the United States, and Kristalose^® (lactulose) for Oral
Solution, a prescription laxative. Cumberland is dedicated to providing
innovative products that improve quality of care for patients. For more
information on Cumberland, please visit the Company's website at

SOURCE Cumberland Pharmaceuticals Inc.

Contact: Investors, Elizabeth Davis, Corporate Relations, +1-615-255-0068,; or Media, Rebecca Kirkham, Lovell
Communications, +1-615-297-7766,
Press spacebar to pause and continue. Press esc to stop.